CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (AMEX: JAV), a leading developer of novel products for pain management, today announced that chief executive officer Martin J. Driscoll, will provide a company overview at the 28th Annual Canaccord Adams Global Growth Conference at 10:30 a.m. EDT on Thursday, August 14, 2008 at the InterContinental Hotel – 510 Atlantic Avenue, in Boston, MA.
